Hemoglobin News and Research

RSS

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.

27 Jan 2010

Promising results in mice could prevent fatal iron buildup in humans

A new study shows that a protein found in blood alleviates anemia, a condition in which the body's tissues don't get enough oxygen from the blood. In this animal study, injections of the protein, known as transferrin, also protected against potentially fatal iron overload in mice with thalassemia, a type of inherited anemia that affects millions of people worldwide.

27 Jan 2010

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

New York Blood Center (NYBC), serving New York City, Long Island, the Hudson Valley, and New Jersey, will donate one dollar to the U.S. Fund for UNICEF for each blood donation made from January 25-31.

25 Jan 2010

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring, and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, jointly announce today CE Mark certification and the European launch of the BMEYE ccNexfin—the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology

21 Jan 2010

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.

20 Jan 2010

Statins may protect SCD children from pneumococcal infection

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

20 Jan 2010

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

A new evidence review suggests that using a pump to deliver insulin continuously — instead of taking three or more daily injections — might result in better control of blood sugar for people with type 1 diabetes.

18 Jan 2010

OSA adversely affects glucose control in patients with type 2 diabetes

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.

18 Jan 2010

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes.

9 Jan 2010

3Sbio submits registrational clinical trial application for Feraheme injection

3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.

8 Jan 2010

St.Vincent Indianapolis Hospital renews campus-wide contract for Masimo SET pulse oximetry technology

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that St.Vincent Indianapolis Hospital has renewed its campus-wide contract for Masimo SET pulse oximetry technology.

31 Dec 2009

NYBC calls for blood donation in recognition of National Blood Donor Month

New York Blood Center (NYBC) and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call upon the community to please donate blood, in recognition of National Blood Donor Month, and to help save lives.

30 Dec 2009

AMA grants new CPT code for Masimo's SpHb measurement

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that the American Medical Association has granted a new Current Procedural Terminology (CPT) code, 88738, for Masimo's noninvasive hemoglobin (SpHb) measurement.

30 Dec 2009

Pharmacists can reduce treatment costs and improve outcomes if given the chance

The role of pharmacists hasn't received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.

30 Dec 2009

ADA recommends the A1C test for diabetes screening and diagnosis

New official guidelines for diabetes screening and diagnosis now include a blood test that gives a person's average blood glucose level over the previous 2-3 months.

30 Dec 2009

Riverside Medical Center launches new diabetes prevention program

Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.

23 Dec 2009

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising.

22 Dec 2009

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes. The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company’s patented Resonator™ system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.

18 Dec 2009

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine.

13 Dec 2009

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Biodel Inc. today reported financial results for the fourth quarter and fiscal year ended September 30, 2009.

10 Dec 2009

Hemoglobin News and Research

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Promising results in mice could prevent fatal iron buildup in humans

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Statins may protect SCD children from pneumococcal infection

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

OSA adversely affects glucose control in patients with type 2 diabetes

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

3Sbio submits registrational clinical trial application for Feraheme injection

St.Vincent Indianapolis Hospital renews campus-wide contract for Masimo SET pulse oximetry technology

NYBC calls for blood donation in recognition of National Blood Donor Month

AMA grants new CPT code for Masimo's SpHb measurement

Pharmacists can reduce treatment costs and improve outcomes if given the chance

ADA recommends the A1C test for diabetes screening and diagnosis

Riverside Medical Center launches new diabetes prevention program

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News